SnapshotDx Quiz: September 2018
August 2018
in “
Journal of Investigative Dermatology
”
TLDR Tofacitinib may help regrow hair in alopecia areata patients.
The document discussed a quiz on alopecia areata (AA) and referenced a study by Jabbari et al. that investigated the use of tofacitinib, a JAK inhibitor, for treating moderate-to-severe AA. This open-label, phase 2 clinical trial included 12 patients and found that 8 of them experienced more than 50% hair regrowth with a dose of 10 mg twice daily. Tofacitinib was generally well-tolerated, with no serious adverse events, suggesting its potential benefit for hair regrowth in AA patients.